Skip to content

Accelerated Muscle Biotechnologies

Accelerated Muscle Biotechnologies (AMB) is a Boston- and Hamburg-based contract research organization specializing in muscle X-ray diffraction and muscle fiber experimentation.

Last updated September 26, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Accelerated Muscle Biotechnologies (AMB) is a contract research organization (CRO) focused on skeletal and cardiac muscle science. Headquartered in Boston, Massachusetts, with a second location in Hamburg, Germany, AMB provides specialized research services to muscle researchers, drug developers, biotechnology companies, and healthcare markets. Its core offerings center on muscle X-ray diffraction and muscle fiber experimentation, including physiological structure-function characterizations, muscle functional assays, and small-angle X-ray diffraction. The company was founded by four partners: two expert muscle physiologists specializing in X-ray diffraction, one muscle modeling scientist, and one business professional with an interest in healthcare-related industries. Their goal was to broaden access to muscle X-ray diffraction methods while also improving data collection hardware and analysis software. Drawing on their own research, the founders innovated ways to speed up and standardize the experimental process, focusing on sample collection hardware, analysis, and interpretation software. They realized that commercializing these innovations into a full-service core facility would provide the cost-effective, high-throughput, high-quality muscle diffraction experimentation sought by drug developers, biotechnology companies, and healthcare markets. AMB operates as a team of career research scientists in skeletal and cardiac muscle mechanics and exercise physiology. Its services include tailored experimental design and preparation, determination and preparation of necessary wet lab equipment, design and fabrication of muscle and X-ray systems to optimize data acquisition and quality, and customized data analysis and interpretation. The company also offers high-throughput processing and statistical analysis of diffraction or mechanical testing data using a semi-automated in-house code base. Muscle fiber experimentation services cover mechanics experiments for permeabilized cardiac and skeletal muscle up to biosafety level S2, as well as biochemistry services such as protein gels, protein raising, and purification. In addition to its CRO activities, AMB functions as a research institution, supporting the academic interests of its scientists who pursue independent academic projects with colleagues via grants from organizations such as the NIH and ERC. The company also works with government partners to accelerate the integration of high-throughput muscle X-ray diffraction into academic, biotech, and healthcare markets. AMB is committed to training the next generation of scientists from diverse backgrounds, addressing a worldwide shortage of qualified X-ray scientists by helping train students and trainees in X-ray theory, practical application during experimental collection, and analysis/interpretation. AMB's leadership includes Dr. Anthony L. Hessel (Chief Executive Officer), Dr. Khoi D. Nguyen (Chief Technology Officer), Michel Kühn (Director of Customer Services), and Anna Good (Chief Operations Officer). The company operates at locations including the LiX beamline at NSLS-II in the USA and maintains a presence in both Boston and Hamburg.

History

Accelerated Muscle Biotechnologies (AMB) was founded by four partners: two expert muscle physiologists specializing in X-ray diffraction, one muscle modeling scientist, and one business professional interested in healthcare-related industries. The founding group aimed to provide access to muscle X-ray diffraction methods to all researchers while also improving data collection hardware and analysis software. Drawing from their own research, the founders began to innovate how muscle X-ray diffraction science was done, with a specific focus on speeding up and standardizing the experimental process, particularly in sample collection hardware, analysis, and interpretation software. From these experiences, they realized that commercializing their innovations into a full-service core facility would provide the cost-effective, high-throughput, high-quality muscle diffraction experimentation craved by drug developers, biotechnology companies, and healthcare markets. The company established operations in Boston, Massachusetts, USA, and Hamburg, Germany. It provides comprehensive services for muscle X-ray diffraction and muscle fiber experimentation. Its muscle X-ray diffraction services include tailored experimental design and preparation, initial project objective refinement and experimental design strategy and feasibility, determination and preparation of necessary wet lab equipment, design, fabrication, and installation of muscle and X-ray systems to optimize data acquisition and quality, and customized data analysis and interpretation. The company also offers high-throughput processing and statistical analysis of diffraction or mechanical testing data acquired either by AMB or others using a semi-automated in-house code base. AMB operates at locations including the LiX beamline at NSLS-II in the USA. In muscle fiber experimentation, AMB provides career muscle scientists and engineers available to consult, support, or directly run muscle research programs. In its laboratories, it carries out many of the most important muscle fiber experiments for clients and collaboration partners, and supports staff scientists to continue their own personal research interests. The company offers both one-stop and piecewise solutions for muscle mechanics experiments from flash frozen or glycerol permeabilized muscle tissue, with mechanics experiments for permeabilized cardiac and skeletal muscle up to biosafety level S2. Biochemistry services such as protein gels, protein raising, and purification are also available depending on research needs. Beyond its CRO activities, AMB functions as a research institution, supporting the academic interests of its scientists who pursue independent academic projects with colleagues via grants from organizations such as the NIH and ERC. The company also works with government partners to accelerate the integration of high-throughput muscle X-ray diffraction into academic, biotech, and healthcare markets. AMB is committed to training the next generation of scientists from diverse backgrounds, especially given a shortage of qualified X-ray scientists worldwide. It helps train students and trainees in X-ray theory, practical application during experimental collection, and analysis/interpretation as time permits. AMB's leadership team includes Dr. Anthony L. Hessel (Chief Executive Officer), Dr. Khoi D. Nguyen (Chief Technology Officer), Michel Kühn (Director of Customer Services), and Anna Good (Chief Operations Officer). Dr. Hessel is a career research scientist with a transdisciplinary research focus covering exercise science, muscle disease, wearable assistive biotechnologies, cardiac/skeletal muscle physiology, protein biophysics, and small-angle X-ray diffraction science. Dr. Nguyen is in charge of data analysis and molecular modeling of skeletal and cardiac muscles and is a subject matter expert in muscle science and imaging technologies, originally trained as a mechanical engineer. Mr. Kühn is an exercise/muscle physiologist focused on mechanical, structural, and cellular adaptations of cardiac and skeletal muscle due to exercise. Ms. Good holds an MBA and serves as Chief Operations Officer.

  • AMB founded by four partners: two muscle physiologists specializing in X-ray diffraction, one muscle modeling scientist, and one business professional.

  • AMB established operations in Boston, MA, USA and Hamburg, Germany.

  • AMB began offering comprehensive muscle X-ray diffraction and muscle fiber experimentation services.

  • AMB initiated work with government partners to accelerate integration of high-throughput muscle X-ray diffraction into academic, biotech, and healthcare markets.

Products and positioning

A specialized contract research organization providing access to advanced muscle X-ray diffraction and muscle fiber experimentation for researchers, drug developers, and biotechnology companies, while also functioning as a research institution and training hub.

  • Muscle X-ray Diffraction

    Comprehensive services for muscle X-ray diffraction experiments, including tailored experimental design, wet lab equipment preparation, design and fabrication of muscle and X-ray systems, and customized data analysis and interpretation.

  • Muscle Fiber Experimentation

    Muscle mechanics experiments for permeabilized cardiac and skeletal muscle up to biosafety level S2, offered as one-stop or piecewise solutions, along with biochemistry services such as protein gels, protein raising, and purification.

Sources4 sources

Cite this profile: Cite the canonical profile. /brand-wiki/accelerated-muscle-biotechnologies-united-states · Editorial policy · How profiles are compiled